Characteristics | Symptomatic 138 (55%) | Asymptomatic 112 (45%) | P values |
Age, years | 54.8±12.7 | 59.0±10.6 | 0.003 |
Gender | 0.014 | ||
Female | 72 (52) | 41 (37) | |
Male | 66 (48) | 71 (63) | |
Race | 0.37 | ||
African-American | 110 (80) | 90 (81) | |
Hispanic | 7 (5) | 6 (5) | |
White | 19 (14) | 11 (10) | |
Other | 1 (1) | 4 (4) | |
Admission HbA1c, % | 9.1±2.9 | 8.2±2.6 | 0.006 |
Duration of diabetes, years | 13.8±9.1 | 14±9.3 | 0.79 |
Diabetes (DM) type | |||
DM type 1 | 11(8) | 6 (5) | 0.46 |
DM type 2 | 127 (92) | 106 (95) | |
# Hypo events, median | 2.0 (1.0, 4.0) | 2.0 (1.0, 3.0) | 0.009 |
Admission BG, mg/dL | 248.2±183 | 220.7±159 | 0.43 |
Outpatient diabetes treatment | 0.24 | ||
No treatment | 6 (4) | 6 (5) | |
Diet only | 8 (6) | 14 (13) | |
Insulin only | 80 (58) | 51 (46) | |
OAD/GLP1 only | 21 (15) | 20 (18) | |
OAD/GLP1+insulin | 23 (17) | 20 (18) | |
Hospital diabetes treatment | |||
Basal+SSI | 45 (33) | 26 (23) | 0.10 |
Basal+bolus | 61 (44) | 48 (43) | 0.83 |
Basal+bolus+OAD | 0 (0) | 2 (2) | 0.20 |
SSI only | 18 (13) | 16 (14) | 0.78 |
OAD+basal insulin | 2 (1) | 8 (7) | 0.046 |
OAD+SSI | 3 (2) | 0 (0) | 0.26 |
GLP1+SSI | 0 (0) | 1 (1) | 0.44 |
No treatment | 9 (7) | 11 (10) | 0.36 |
Blood glucose during hypoglycemia episode | |||
Mean BG during hypoglycemia, mg/dL | 53.8±11.4 | 60.0±8.3 | <0.001 |
BG values between 60 mg/dL and 69 mg/dL, n (%) | 58 (42) | 73 (65) | |
BG values between 40 mg/dL and 59 mg/dL, n (%) | 63 (46) | 37 (33) | |
BG values <54 mg/dL, n (%) | 60 (43) | 22 (20) | |
BG values <40 mg/dL, n (%) | 17 (12) | 2 (2) |
Data are n (%), mean±SD or median (IQR).
To convert HbA1c value in % to mmol/mol=10.93 × %HbA1c value − 23.5), BG value in mg/dlL to mmol/L=BG mg/dL value / 18.
DM, diabetes mellitus;BG, blood glucose; GLP-1, Glucagon-like peptide 1; OAD, Oral antidiabetic drug; SSI, sliding scale insulin.